1 follower
InterVenn Biosciences utilizes a proprietary high-throughput glycoproteomic interrogation platform using artificial intelligence and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together wi... Read more
Joshua Stahl
SpringWorks Therapeutics
4 followers
Owkin
4 followers
Quantum-Si
2 followers
EyePoint Pharmaceuticals
2 followers
Spero Therapeutics
2 followers
Gene by Gene
2 followers
Entrada Therapeutics
1 follower
Newlight Technologies
1 follower
Abeona Therapeutics
1 follower
Thermo Fisher Scientific
144 followers
Gilead Sciences
121 followers
Discover companies